Abstract:Background and aims: Effective hepatic blood flow (EHBF) decreases with liver disease progression, and identifying liver pathology is critical for patients with liver disease. This study was designed to elucidate the correlation between EHBF and liver pathology and explore the potential of EHBF for predicting the degree of liver pathology. Methods: In this study, 207 patients with hepatitis B virus (HBV) who underwent liver biopsy and indocyanine green (ICG) clearance tests were enrolled. EHBF was measured using the ICG clearance test, and liver tissue was histologically analyzed to determine the pathological stage according to the Scheuer scoring system. Demographic data, biochemical indexes, and FibroScan data were collected for statistical analysis. Results: EHBF levels decreased as the liver histological stages of inflammation and fibrosis increased (P < 0.01). EHBF was significantly negatively associated with the levels of alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transpeptidase, alkaline phosphatase, aspartate aminotransferase-to-platelet ratio index, fibrosis index based on the four factors, and liver stiffness measurement (P < 0.05). The EHBF levels of patients without liver inflammation (G0) were significantly higher than those of patients with liver inflammation (G1-4) (P < 0.001). The area under the receiver operating characteristic curve (AUROC) value for discriminating patients without liver inflammation was 0.827, and the optimal cutoff value was 0.936 L/min. The EHBF levels of patients with severe liver inflammation (G4) were significantly lower than those of patients with G0-3 liver inflammation (P < 0.001). The AUROC value for discriminating patients with severe liver inflammation was 0.792, and the optimal cutoff value was 0.552 L/min. The EHBF levels of patients without liver fibrosis (S0) were significantly higher than those of patients with liver fibrosis (S1-4) (P < 0.001). The AUROC value for discriminating patients without liver fibrosis was 0.633, and the optimal cutoff value was 1.173 L/min. The EHBF levels of patients with liver cirrhosis (S4) were significantly lower than those of patients with S0-3 liver fibrosis (P < 0.001). The AUROC value for discriminating patients with liver cirrhosis (S4) was 0.630, and the optimal cutoff value was 0.562 L/min. Conclusions: EHBF levels and liver pathology are significantly correlated. EHBF could effectively reflect liver inflammation and fibrosis in patients infected with HBV, especially for patients without liver inflammation or liver fibrosis. (c) 2021 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Clinical significance of pulse dye densitometry in effective hepatic blood flow detection

The Clinical Significance of Indocyanine Green Excretion Test in Evaluation of Liver Functional Reserve

Clinical Application of ICG Clearance Test for Hepatic Reserve Function by Pulse Dye Densitometry

Indocyanine Green Retention is a Potential Prognostic Indicator after Splenectomy and Pericardial Devascularization for Cirrhotic Patients

Preoperative prediction of hepatic blood flow and hepatic functional cell resecting ratio in patients with primary liver cancer

Indocyanine Green Clearance in Evaluating the Recovery of Liver Reserve Function after Superselective Transarterial Chemoembolization

Non-invasive Monitoring of Hepatic Blood Flow in Anesthesia Practice

Noninvasive assessment of liver function reserve with fluorescent dosimetry of indocyanine green

Preoperative Detection of Liver Functional Reserve in Patients with Hilar Cholangiocarcinoma Using the Indocyanine Green Retention Test

Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma

Correlation of Effective Hepatic Blood Flow with Liver Pathology in Patients with Hepatitis B Virus

Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy

[Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma]

Perfusion of hepatocellular carcinomas measured by diffusion‐derived vessel density biomarker: Higher hepatocellular carcinoma perfusion than earlier intravoxel incoherent motion reports

The clinical value of dual-energy CT-based iodine quantification parameters in the evaluation of hemodynamics and liver function in patients with cirrhosis

Functional hepatic flow can predict the hepatic reserve function in surgical cirrhotic patients.

Association Between Effective Hepatic Blood Flow And The Severity And Prognosis Of Hepatitis B Virus-Related Acute On Chronic Liver Failure

Value of perfusion parameters and histogram analysis of triphasic computed tomography in pre-operative prediction of histological grade of hepatocellular carcinoma

Imaging biomarker evaluation for microcirculatory functional status of hepatocellular carcinoma using IVIM-DWI

Quantitative assessment of liver function with hepatocyte fraction: Comparison with T1 relaxation‐based indices

Preoperative Remnant Liver Function Evaluation Using a Routine Clinical Dynamic Gd-EOB-DTPA-Enhanced MRI Protocol in Patients with Hepatocellular Carcinoma